Even with all of the cancer based research that is taking place across the globe, we can see that millions of people still die each day due to this disease. To be more specific, the World Health Organization has released studies which show that a person is diagnosed with some form of cancer every 10 minutes.
Thus, it is clear that the solution for such a problem is the early detection of the disease, rather than its treatment (after its onset).
Existing Treatment Methods
While there are a wide array of diagnostic and cancer treatment methods available in the market today, the core ones that are most commonly used include:
- Magnetic resonance
- Ultrasound Visual
All of these aforementioned methods allow us to study tumours and get a detailed idea of their structure and shape. However, these methods are not able to accurately allow for the early detection of the disease.
What Is Luven Offering?
In its core essence, Luven is offering customers with all new “cancer detection technology” that allows for the early recognition of the condition, thereby arresting its spread throughout the patient's body.
It makes use of “Radioimmunoassay based treatment methods” that are known to be effective against all types of malignant tumors. In addition to this, these assays induce the blood with “low immunogenicity” proteins which start to accumulate within one’s body as soon as the disease starts to set in. This helps in identifying the problem timely, without much hassle.
Other Key Information to Keep in Mind
Apart from all of the above details, the “carcinoembryonic antigens” that act as the prime indicators for cancer are detected timely via the use of Luven’s new detection+treatment method.
With this treatment method, customers are provided with high diagnostic accuracy at an extremely affordable rate.
Instead of patients having to undergo countless tests, the Luven method replaces all of the tests with one single examination. The exam is extremely pain free, and can be completed within a matter of minutes.
(iv) Peripheral Checks:
In addition to checking for cancer based symptoms, this test can also be used to check the health of our other internal organs.
(v) Early Diagnosis:
As mentioned earlier, this method allows for the early detection of cancer (at a time when there are no visible signs of the condition).
The Luven diagnostic method is extremely quick, and is able to provide results within a short span of 15 minutes.
One of the key benefits of this method is that it can be carried around and used in areas with no hospitals or laboratories.
Through the use of periodic checkups, this method helps eliminates the need of non-effective drug therapies.
How Does It All Work?
(i) Preliminary Data Supply:
To start proceedings off, a patient is required to fill out the necessary forms (this can be done via the use of the native computer app created by the company).
Following this, a ‘buccal swab’ is collected via the use of a spatula and viewed under a microscope.
The computer system then “records a video of the microscopic data” and then starts to analyse the obtained information.
(iv) Final Report:
After all of the data has been thoroughly scrutinized, a detailed report is then delivered to the patient (outlining all of one’s crucial health related information).
According to the official company whitepaper, Luven has already raised 90% of the required money via the use of grants. For the remaining sum, the company has taken the crowdfunding route.
Token buyers will have two primary options
- Receive a part of the company income.
- Exchanging their tokens for testing services (30% discount) Not only that, token holders will also be able to sell these tokens to clinics, insurance companies, physicians etc.
The Token Sale Will Take Place in Two Phases…
(i) Pre- ICO:
During this period, there will be a total of 3,000,000 tokens that will be released to potential investors. There will be various incentives to avail of including:
- 1st day bonus : 30%
- 1st week bonus : 25%
- 2nd week bonus – 20%
- 3rd week bonus – 15%
This will serve as the main crowdsale period, and will allow users to obtain a total of 27,000,000 tokens. This phase is scheduled to commence on the 15th of January and conclude on the 28th of February 2018.
At this point, it should also be mentioned that a total of 9,000,000 tokens will be kept by the founders and developers of Luven Diagnostic. The native coin will be ERC20 compliant and can be bought via the use of Ethereum as well as Bitcoin. In terms of its pricing, we can see 1 Eth = 290 tokens.
Luven ICO Allocation of Funds
- 50% of all raised revenue will be used directly to fund the technology at hand.
- The remaining 50% will be made available to token holders via different incentive schemes.
Who Is Behind This Project?
According to information that is available online, this diagnostic tool is the brainchild of Ms. Galina Shchukina, who is a “genetic scientist and cytologist”. She is the one responsible for conducting all of the core research that has laid the foundation for this entire project. Similarly, Mr. Alexander Shchukin is a nuclear physicist who has furthered the research and come up with a tangible treatment model (for which the company is now looking to raise funds for).
For any further details regarding the technology/ICO, customers can write to company representatives on the email address provided on the official website.